Ketogenic diet for super-refractory seizure emergency
Part of Brain & nervous system clinical trials.
This trial tests if a high-fat, low-carb diet (ketogenic diet) can help stop seizures that have not responded to other treatments. It is for patients with a very severe, ongoing seizure emergency called super-refractory status epilepticus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your seizures have continued or come back after at least 24 hours of standard hospital treatment, including medications and anesthesia.
- You are between 14 and 80 years old.
- You do not have a fatty acid metabolism disorder or porphyria.
- You have not received propofol in the last 24 hours.
- You do not have liver failure, pancreatitis, severe infection, or unstable blood pressure.
- You can safely receive nutrition through a feeding tube.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking ketone esters (a special form of ketones) can help stop refractory generalized convulsive status epilepticus (a seizure emergency that is hard to control). If you qualify, the study team will check safety closely, especially your breathing, heart stability, and blood sugar/acid levels.
This study looks at whether a special high-fat, low-carbohydrate diet can help reduce seizures in adults whose epilepsy has not improved with two or more medications. It is an observational study, meaning participants follow the diet as part of their regular care and the research team tracks their progress.
This trial studies how well a ketogenic diet works for children with hard-to-treat epilepsy or certain other diseases. It aims to see if the diet improves quality of life.
This trial tests whether taking “ketone ester” supplements can reduce seizures in people with drug-resistant epilepsy. It may help by changing how the brain uses energy, but you must meet several safety and diet-related conditions.
This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.
This study tests whether ketamine can help stop seizures that haven't responded to standard treatments. It's for people with a serious condition called status epilepticus, where seizures don't stop on their own.
Hear when a new Super-refractory Status Epilepticus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.